ARDT

Profile

Full Name

Ardent Health Partners, Inc.

Ticker Symbol

ARDT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

Indexes

Not included

Website

http://www.ardenthealth.com

Employees

19200

Key Details

Price

$12.30(-0.97%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.97B(+10.29% YoY)

Annual EPS

$1.58(+313.18% YoY)

PE ratio

8.06

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$12.30
ARDT price is $12.30

30-Day Relative Volume

0.83
ARDT 30-day relative volume is 0.83

Price Performance

Price Most recent change

-0.97%
ARDT price was down -0.97% on Apr 15, 2025

Price YTD change

-27.99%
ARDT price is down -27.99% since January 1st

Price 1-year change

-
ARDT price 1-year change is unknown

Price 3-year change

-
ARDT price 3-year change is unknown

Price Range

Price All-time high

$20.72
ARDT price is currently -40.64% below its historical high of $20.72

Price 3-year low

$11.60
ARDT price is currently +6.03% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.76B
ARDT market capitalization is $1.76 billion

Market cap 3-year change

-
ARDT market capitalization 3-year change is unknown

Market cap All-time high

$2.95B
ARDT market capitalization is currently -40.57% below its historical high of $2.95 billion

Market cap sector rank

81.91%
ARDT market capitalization is higher than 81.91% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.27%
ARDT shares outstanding is up +1.27% year-on-year

Shares Outstanding 3-Year Change

-
ARDT shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.53
ARDT beta is 0.53

200-day SMA

$16.26
ARDT price is currently -24.33% below its 200-day simple moving average

50-day SMA

$13.87
ARDT price is currently -11.34% below its 50-day simple moving average

RSI

41.91
ARDT 14-day relative strength index is 41.91

Volume

0.83
ARDT 30-day relative volume is 0.83

ATR

$0.64
ARDT average true range is $0.64

10-day Historical Volatility

59.31%
ARDT 10-day historical volatility is 59.31%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.97B
ARDT annual revenue is $5.97 billion

Revenue Analysts estimate

$6.33B
ARDT annual revenue is currently -5.68% lower than the consensus analysts' forecast

Revenue 1-year change

+10.29%
ARDT annual revenue is up +10.29% year-on-year

Revenue Sector rank

92.5%
ARDT annual revenue is higher than 92.5% of companies in Healthcare sector

EPS

EPS

$1.58
ARDT annual earnings per share is $1.58

EPS Analysts estimate

$1.91
ARDT annual earnings per share is currently -17.13% lower than the consensus analysts' forecast

EPS 1-year change

+313.18%
ARDT annual earnings per share is up +313.18% year-on-year

EPS Sector rank

91.23%
ARDT annual earnings per share is higher than 91.23% of companies in Healthcare sector

Profit

Gross profit

$4.93B
ARDT annual gross profit is $4.93 billion

Gross margin

82.68%
ARDT annual gross profit margin is 82.68%

Operating profit

$405.76M
ARDT annual operating income is $405.76 million

Operating margin

6.80%
ARDT annual operating profit margin is 6.80%

Net income

$210.34M
ARDT annual net profit is $210.34 million

Net margin

3.53%
ARDT annual net profit margin is 3.53%

Expenses

Total expenses

$5.56B
ARDT annual total expenses is $5.56 billion

Operating expenses

$4.53B
ARDT annual total operating expenses is $4.53 billion

Cost of goods sold

$1.03B
ARDT annual cost of goods sold is $1.03 billion

Selling, general & administrative expenses

$3.88B
ARDT annual SGA is $3.88 billion

Depreciation and amortization

$146.29M
ARDT annual depreciation & amortization is $146.29 million

Interest expense

$65.58M
ARDT annual interest expense is $65.58 million

Income tax

$63.35M
ARDT annual income tax is $63.35 million

EBIT & EBITDA

EBIT

$428.64M
ARDT annual earnings before interest & taxes is $428.64 million

EBITDA

$574.93M
ARDT annual EBITDA is $574.93 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.96B
ARDT annual total assets is $4.96 billion

Non current assets

$3.12B
ARDT annual long term assets is $3.12 billion

Current assets

$1.83B
ARDT annual total current assets is $1.83 billion

Cash and cash equivalents

$556.78M
ARDT annual cash & cash equivalents is $556.78 million

Accounts receivable

$743.03M
ARDT annual accounts receivable is $743.03 million

Inventory

$115.09M
ARDT annual inventory is $115.09 million

Liabilities

Total liabilities

$3.43B
ARDT annual total liabilities is $3.43 billion

Long term liabilities

$2.49B
ARDT annual total long term liabilities is $2.49 billion

Current liabilities

$945.42M
ARDT annual total current liabilities is $945.42 million

Accounts payable

$401.25M
ARDT annual accounts payable is $401.25 million

Debt

Total debt

$2.28B
ARDT annual total debt is $2.28 billion

Total debt 1-year change

-4.77%
ARDT annual total debt is down -4.77% year-on-year

Long term debt

$2.23B
ARDT annual long term debt is $2.23 billion

Short term debt

$55.62M
ARDT annual short term debt is $55.62 million

Equity & Capital

Shareholders equity

$0.00
ARDT annual stockholders equity is $0.00

Book value

$1.13B
ARDT annual book value is $1.13 billion

Retained earnings

$365.80M
ARDT annual retained earnings is $365.80 million

Working capital

$887.33M
ARDT annual working capital is $887.33 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$315.03M
ARDT annual cash flow from operations is $315.03 million

Cash from operations 1-year change

+42.1%
ARDT annual cash flow from operations is up +42.1% year-on-year

Cash from investing

-$220.46M
ARDT annual cash flow from investing activities is -$220.46 million

Cash from investing 1-year change

-59.77%
ARDT annual cash flow from investing activities is down -59.77% year-on-year

Cash from financing

$24.64M
ARDT annual cash flow from financing activities is $24.64 million

Cash from financing 1-year change

+124.1%
ARDT annual cash flow from financing activities is up +124.1% year-on-year

CAPEX

CAPEX

$187.51M
ARDT annual capital expenditures is $187.51 million

CAPEX 1-year change

+36.46%
ARDT annual capital expenditures is up +36.46% year-on-year

Free Cash Flow

Free cash flow

$127.52M
ARDT annual free cash flow is $127.52 million

Free cash flow 1-year change

+51.28%
ARDT annual free cash flow is up +51.28% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

82.68%
ARDT annual gross profit margin is 82.68%

Operating margin

6.80%
ARDT annual operating profit margin is 6.80%

Net margin

3.53%
ARDT annual net profit margin is 3.53%

ROA & ROE

ROA

4.34%
ARDT annual return on assets is 4.34%

ROE

16.15%
ARDT annual return on equity is 16.15%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

8.06
ARDT price to earnings ratio is 8.06

PE ratio Sector rank

11.76%
ARDT price to earnings ratio is higher than 11.76% of companies in Healthcare sector

PB Ratio

PB ratio

1.55
ARDT price to book ratio is 1.55

PB ratio Sector rank

56.63%
ARDT price to book ratio is higher than 56.63% of companies in Healthcare sector

PS Ratio

PS ratio

0.29
ARDT price to sales ratio is 0.29

PS ratio Sector rank

10%
ARDT price to sales ratio is higher than 10% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.48B
ARDT enterprise value is $3.48 billion

Enterprise value Sector rank

86.03%
ARDT enterprise value is higher than 86.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.09
ARDT EV/EBITDA is 6.09

EV/EBITDA Sector rank

79.04%
ARDT EV/EBITDA is higher than 79.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.94
ARDT annual current ratio is 1.94

Quick ratio

1.82
ARDT annual quick ratio is 1.82

Leverage

Debt to equity

-
ARDT annual debt to equity ratio value is unknown

Interest coverage ratio

6.54
ARDT annual interest coverage ratio is 6.54

Risk & Stability

Piotroski F-Score

-
ARDT piotroski f-score value is unknown

Altman Z-Score

2.11
ARDT altman z-score is 2.11

Analyst ratings

Recent major analysts updates

Apr 9, 25 Mizuho
Outperform
Apr 9, 25 Guggenheim
Buy
Apr 1, 25 Stephens & Co.
Overweight
Mar 26, 25 Stephens & Co.
Overweight
Mar 4, 25 RBC Capital
Outperform
Feb 27, 25 Stephens & Co.
Overweight
Jan 21, 25 Morgan Stanley
Overweight
Jan 6, 25 Truist Securities
Buy
Nov 14, 24 RBC Capital
Outperform
Nov 12, 24 Leerink Partners
Outperform

Institutional Ownership

Similar stocks

SUPN logo
Supernus Pharmaceuticals (SUPN)
NAMS logo
NewAmsterdam Pharma Company NV (NAMS)
PINC logo
Premier (PINC)
Ascentage Pharma Group International (AAPG)
WRBY logo
Warby Parker (WRBY)
GDRX logo
GoodRx Holdings (GDRX)
QDEL logo
QuidelOrtho (QDEL)
ENOV logo
Enovis (ENOV)
JANX logo
Janux Therapeutics (JANX)
  • What is the ticker symbol for Ardent Health Partners LLC?
  • Does Ardent Health Partners LLC pay dividends?
  • What sector is Ardent Health Partners LLC in?
  • What industry is Ardent Health Partners LLC in?
  • What country is Ardent Health Partners LLC based in?
  • Is Ardent Health Partners LLC in the S&P 500?
  • Is Ardent Health Partners LLC in the NASDAQ 100?
  • Is Ardent Health Partners LLC in the Dow Jones?
  • When was Ardent Health Partners LLC's last earnings report?
  • When does Ardent Health Partners LLC report earnings?
  • Should I buy Ardent Health Partners LLC stock now?

What is the ticker symbol for Ardent Health Partners LLC?

The ticker symbol for Ardent Health Partners LLC is NYSE:ARDT

Does Ardent Health Partners LLC pay dividends?

No, Ardent Health Partners LLC does not pay dividends

What sector is Ardent Health Partners LLC in?

Ardent Health Partners LLC is in the Healthcare sector

What industry is Ardent Health Partners LLC in?

Ardent Health Partners LLC is in the Medical Care Facilities industry

What country is Ardent Health Partners LLC based in?

Ardent Health Partners LLC is headquartered in United States

Is Ardent Health Partners LLC in the S&P 500?

No, Ardent Health Partners LLC is not included in the S&P 500 index

Is Ardent Health Partners LLC in the NASDAQ 100?

No, Ardent Health Partners LLC is not included in the NASDAQ 100 index

Is Ardent Health Partners LLC in the Dow Jones?

No, Ardent Health Partners LLC is not included in the Dow Jones index

When was Ardent Health Partners LLC's last earnings report?

Ardent Health Partners LLC's most recent earnings report was on Feb 26, 2025

When does Ardent Health Partners LLC report earnings?

The next expected earnings date for Ardent Health Partners LLC is May 30, 2025

Should I buy Ardent Health Partners LLC stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page